---
figid: PMC11206589__nutrients-16-01883-g003
figtitle: Suggested anticancer molecular mechanisms of sulforaphane
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC11206589
filename: nutrients-16-01883-g003.jpg
figlink: /pmc/articles/PMC11206589/figure/F3
number: F3
caption: Suggested anticancer molecular mechanisms of sulforaphane. It induces ()
  cytotoxicity and reduces () cancer cells proliferation primarily by (I) modulating
  the expression of genes crucial for cell differentiation and proliferation via the
  phosphatase and tensin homolog (PTEN), phosphoinositide 3-kinases (PI3K), and serine/threonine
  protein kinase (AKT) signaling pathways; via inhibitors of nuclear factor-kappa-B
  kinase subunit alpha and beta (IKK-α,β) and nuclear factor-kappa-B (NF-κB), inhibiting
  () DNA methyltransferases (DNMTs) and histone deacetylases (HDACs); and via nuclear
  factor erythroid 2-related factor 2 (NRF2) by binding antioxidant response elements
  (AREs); (II) inducing cell death by apoptosis via Bcl-2-associated X (Bax); B-cell
  lymphoma 2 (Bcl-2); cytochrome complex (Cyt C); caspases 8, 9, and 3; and by autophagy
  via microtubule-associated protein light chain 3 I,II (LC3 I,II); (III) blocking
  the cell cycle by inhibiting cyclins D, A, and B through the activation of p21 and
  p27; (IV) having an immunomodulatory effect by reducing the production of IL-1β,
  IL-4, IL-6 (interleukin), interferon-gamma (IFN-γ), and tumor necrosis factor (TNF-α)
  and via the proteolytic cleavage of clusters of differentiation 44 (CD44); and (V)
  reducing inflammation by inhibiting cycloox-ygenase-2 (COX-2), prostaglandin E2
  (PGE2), vascular endothelial growth factor (VEGF), and platelet-derived growth factor
  (PDGF). Created with BioRender.com. “https://app.biorender.com/illustrations/661e36e12bb8f001aab26646
  (accessed on 16 April 2024)”
papertitle: Synergic Role of Dietary Bioactive Compounds in Breast Cancer Chemoprevention
  and Combination Therapies
reftext: Marisabel Mecca, et al. Nutrients. 2024 Jun;16(12).
year: '2024'
doi: 10.3390/nu16121883
journal_title: Nutrients
journal_nlm_ta: Nutrients
publisher_name: MDPI
keywords: phytochemicals | diet | breast cancer | cancer prevention | PUFA | bromelain
  | isothiocyanate | glucosinolates
automl_pathway: 0.7582483
figid_alias: PMC11206589__F3
figtype: Figure
redirect_from: /figures/PMC11206589__F3
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC11206589__nutrients-16-01883-g003.html
  '@type': Dataset
  description: Suggested anticancer molecular mechanisms of sulforaphane. It induces
    () cytotoxicity and reduces () cancer cells proliferation primarily by (I) modulating
    the expression of genes crucial for cell differentiation and proliferation via
    the phosphatase and tensin homolog (PTEN), phosphoinositide 3-kinases (PI3K),
    and serine/threonine protein kinase (AKT) signaling pathways; via inhibitors of
    nuclear factor-kappa-B kinase subunit alpha and beta (IKK-α,β) and nuclear factor-kappa-B
    (NF-κB), inhibiting () DNA methyltransferases (DNMTs) and histone deacetylases
    (HDACs); and via nuclear factor erythroid 2-related factor 2 (NRF2) by binding
    antioxidant response elements (AREs); (II) inducing cell death by apoptosis via
    Bcl-2-associated X (Bax); B-cell lymphoma 2 (Bcl-2); cytochrome complex (Cyt C);
    caspases 8, 9, and 3; and by autophagy via microtubule-associated protein light
    chain 3 I,II (LC3 I,II); (III) blocking the cell cycle by inhibiting cyclins D,
    A, and B through the activation of p21 and p27; (IV) having an immunomodulatory
    effect by reducing the production of IL-1β, IL-4, IL-6 (interleukin), interferon-gamma
    (IFN-γ), and tumor necrosis factor (TNF-α) and via the proteolytic cleavage of
    clusters of differentiation 44 (CD44); and (V) reducing inflammation by inhibiting
    cycloox-ygenase-2 (COX-2), prostaglandin E2 (PGE2), vascular endothelial growth
    factor (VEGF), and platelet-derived growth factor (PDGF). Created with BioRender.com.
    “https://app.biorender.com/illustrations/661e36e12bb8f001aab26646 (accessed on
    16 April 2024)”
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MAP1LC3A
  - BCL2
  - BAX
  - CDKN1A
  - TCEAL1
  - NSG1
  - H3P16
  - PTGS2
  - CD44
  - PTEN
  - CDK4
  - CDK6
  - CCND1
  - CCND2
  - CCND3
  - GABPA
  - NFE2L2
  - CASP1
  - CASP2
  - CASP4
  - CASP5
  - CASP6
  - CASP8
  - CASP9
  - CASP10
  - CASP12
  - CASP14
  - CASP3
  - CASP7
  - NFKB1
  - CDK1
  - POLD1
  - CCNB1
  - CCNB2
  - CCNB3
  - GNAS
  - GNAL
  - PDGFA
  - PDGFB
  - PDGFC
  - PDGFD
  - HDAC9
  - HDAC1
  - HDAC2
  - HDAC3
  - HDAC8
  - HDAC4
  - HDAC5
  - HDAC7
  - HDAC6
  - HDAC10
  - SIRT1
  - SIRT2
  - SIRT3
  - SIRT4
  - SIRT5
  - SIRT6
  - SIRT7
  - HDAC11
  - WARS1
  - AKT1
  - AKT2
  - AKT3
  - CDK2
  - CCNA1
  - CCNA2
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - PGF
  - HMOX1
  - CAT
  - CRAT
  - GLYAT
  - SOD1
  - SOD2
  - SOD3
  - GCLC
  - ZBTB20
  - IFI27
  - PSMD9
  - ZNRD2
  - DCTN6
  - TMED7
  - H3P23
  - IL1B
  - IL6
  - IL4
  - TNF
  - Sulforaphane
  - PGE2
  - Nucleus
  - Cancer
---
